Amazon’s new smart pillow for sleep is designed to treat and detect snoring by adjusting your head to open your airways — ...

A release date and price is yet to be announced and the U.S. Food and Drug Administration (FDA) has not approved the device for sleep apnea detection yet, but the inventors at Amazon Technologies ...

Inspire Medical Systems (NYSE:INSP) shares dipped today on third-quarter results that came in ahead of the consensus forecast ...

Partnership aims to reduce barriers to care by putting patients in control of their own health journey and enabling nightly monitoring to enhance early stage detection MADISON, Wis., Oct. 31, 2024 ...

H.C. Wainwright analyst Edward White has reiterated their bullish stance on NYXH stock, giving a Buy rating on November 5. Edward White has ...

Inspire is increasing its full year 2024 revenue guidance to between $793 million to $798 million, which represents growth of 27% to 28% over full year 2023 revenue of $624.8 million. This compares to ...

Inspire Medical Systems topped Q3 expectations, signaling continued market strength and innovation.

Among potential surgeries for sleep apnea is UPPP (uvulopalatopharyngoplasty) surgery, which involves removing part of the ...

Sleep apnea detection isn’t unique to the Apple Watch, but it is one of the hottest wearables trends of 2024. Apple gained FDA approval in the middle of September – a few days before the Apple ...

minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA, EU MDR and PDMA-approved neurostimulation technology of ...